The World Health Organisation (WHO) has commenced clinical trial in the Democratic Republic of Congo (DRC), to evaluate two experimental treatments for Bundibugyo Virus Disease (BVD), a rare form of Ebola.
In May, WHO declared the Ebola outbreak in DRC and Uganda a public health emergency of international concern.
WHO said the outbreak does not meet the threshold for a pandemic emergency under the international health regulations.
The agency said the declaration followed consultations with authorities in DRC and Uganda over the escalating spread of the virus and the risk of cross-border transmission.
On Wednesday, the United Nations Development Programme (UNDP) said the ongoing Ebola crisis in Central and East Africa could cost the continent as much as $3.6 billion in economic output and wipe out more than 328,000 jobs if the virus spreads beyond its current hotspots.
In a statement on Thursday,
